Results

Total Results: 1,965 records

Showing results for "neurological".

  1. effectivehealthcare.ahrq.gov/health-topics/encephalitis
  2. effectivehealthcare.ahrq.gov/health-topics/amyotrophic-lateral-sclerosis
  3. effectivehealthcare.ahrq.gov/health-topics/huntingtons-disease
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-rapid-review.pdf
    December 01, 2024 - and surgical patients, and the other study, by Weller et al.,14 looked at unexpected mortality in neurological … .35 The other studies found no improvement in mortality, but one was in a restricted population of neurological … Evaluation of a wireless, portable, wearable multi-parameter vital signs monitor in hospitalized neurological
  5. hcup-us.ahrq.gov/reports/methods/2020-04.pdf
    January 01, 2020 - respiratory or circulatory disease, craniofacial anomalies, neuromuscular disorders, or degenerative neurological … software, diabetes must be the principal diagnosis and long-term complications include renal, eye, neurological … respiratory or circulatory disease, craniofacial anomalies, neuromuscular disorders, or degenerative neurological
  6. psnet.ahrq.gov/web-mm/perioperative-anaphylaxis-after-insertion-latex-drain-patient-known-latex-allergy
    July 08, 2022 - SPOTLIGHT CASE Perioperative Anaphylaxis After Insertion of a Latex Drain in a Patient with Known Latex Allergy Citation Text: Kelly KJ. Perioperative Anaphylaxis After Insertion of a Latex Drain in a Patient with Known Latex Allergy. PSNet [internet]. Rockville (MD): Agency for Healthcare Resear…
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
    November 19, 2009 - Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations Medical Tests—White Paper Series Decision-Analytic Modeling to Evaluate Benefits and Harms of Medical Tests— Uses and Limitations The findings and conclusions in thi…
  8. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/mhs-IV-epc-grand-rounds-slides.pptx
    January 01, 2023 - AHRQ Slide Template 2019-Widescreen AHRQ Evidence-based Practice Center Program Grand Rounds Series Making Healthcare Safer IV Reports Welcome! Logistics This meeting will be recorded and shared externally. Please use the chat for questions and feedback throughout the session or use the hand-raising functionality …
  9. www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
    August 01, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication August 01, 2023 Recommendations made by the USPSTF are in…
  10. 0129Table8 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0129table8.pdf
    January 01, 2013 - Table 8 – Evidence for the Relationship between Readmission and Quality of Care Type of Evidence Key Findings Citation Readmission and Quality of Care Coordination, Discharge, and Care Transition Processes Meta-analysis Investigators reviewed randomized controlled studies of structured telephone support or t…
  11. www.ahrq.gov/diagnostic-safety/resources/issue-briefs/dxsafety-test-result-communication-references.html
    July 01, 2024 - Electronic Test Result Communication in the Era of the 21st Century Cures Act References Previous Page Next Page Table of Contents Electronic Test Result Communication in the Era of the 21st Century Cures Act Introduction Methods Results Discussion Conclusions References Appendix A. Da…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
    August 01, 2012 - the effectiveness of FGAs and SGAs with patient subpopulations, including patients with medical and neurological
  13. hcup-us.ahrq.gov/db/nation/nis/NISvariables1988-2014forHCUP-US.pdf
    October 14, 2016 - Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes CM_METS CM_NEURO Severity AHRQ comorbidity measure: Other neurological
  14. hcup-us.ahrq.gov/db/nation/nis/NISvariables1988-2012forHCUP-US.pdf
    May 14, 2013 - Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes CM_METS CM_NEURO Severity AHRQ comorbidity measure: Other neurological
  15. References (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/ltvv-litreview.docx
    January 01, 2017 - tended to be lower, and duration of intubation and duration of SICU stay tended to be shorter for non-neurological
  16. www.ahrq.gov/hai/tools/mvp/modules/technical/ltvv-lit-review.html
    January 01, 2017 - tended to be lower, and duration of intubation and duration of SICU stay tended to be shorter for non-neurological
  17. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
    January 01, 2012 - measure: Metastatic cancer 7,296,968 0 0.00 1.00 0.02 0.13 CM_NEURO : AHRQ comorbidity measure: Other neurological
  18. www.ahrq.gov/sites/default/files/wysiwyg/diagnostic/resources/issue-briefs/dxsafety-ehr-impact.pdf
    August 01, 2024 - The accuracy of bedside neurological diagnoses.
  19. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
    January 01, 2014 - measure: Metastatic cancer 14,894,613 0 0.00 1.00 0.02 0.14 CM_NEURO : AHRQ comorbidity measure: Other neurological
  20. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
    October 31, 2017 - measure: Metastatic cancer 12,927,179 0 0.00 1.00 0.02 0.14 CM_NEURO : AHRQ comorbidity measure: Other neurological